Associate Professor Andrew Strickland is a medical oncologist and clinical researcher specialising in gastrointestinal cancer including neuroendocrine tumours. He graduated from Melbourne University and completed his training in medical oncology with the Royal Australian College of Physicians. He subsequently undertook a fellowship at Guy’s Hospital in London where he worked in the area of upper gastrointestinal cancer.
He is experienced in the management of patients with a wide range of tumours but his sole focus now is gastrointestinal (GI) cancer. He was instrumental in establishing the gastrointestinal cancer clinics at Monash and in collaboration with his surgical and radiation oncology colleagues established the GI cancer multidisciplinary team meetings. More recently he has organised a multidisciplinary team meeting for neuroendocrine tumours which is the only specialised NET MDT in Melbourne.
He is the principal investigator on a large number of clinical trials in gastrointestinal cancer at Monash and enrols significant numbers of patients onto these trials. He plays a major role in the co-ordination of these studies and regularly attends investigator meetings to discuss current and prospective clinical trials.
Associate Professor Strickland is an active member of the Australian Gastrointestinal Trials Group (AGITG), the Medical Oncology Group of Australia (MOGA) and the American Society of Clinical Oncology (ASCO). He has published over 50 peer reviewed articles and reviews and has acted as a reviewer for a number of journals.